Online Public Relations Thoughts

Johnson & Johnson has had to scrap 15 million doses of its COVID vaccine because of manufacturing errors at its production partner.  This comes after J&J trumpeted its linkup with the company, Emergent BioSolutions.  Now, dirty laundry is being aired with reports of Food and Drug Administration citations against Emergent for ill training, mold and other manufacturing errors.  J&J is insisting it will meet its goals of delivering 100 million doses by the end of May, but trust has been strained because of the mistake and the company has had to bolster its presence in Emergent's plant.  The public will decide next whether to take the J&J vaccine or wait for another.  There is hesitancy, and this mistake doesn't help.  The only marketing solution for J&J is to make sure it never happens again.